Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
Researchers from the University of Rochester are teaming up with scientists from the College of Veterinary Medicine at Cornell University to study Inflammation, which plays a role in nine of the top 10 causes of death worldwide.
11/20/2014 | 0 comments
Exciting new studies of targeted cancer treatments, the amazing longevity of bowhead whales, and the changing roles of pathologists were among the topics covered at the 19th Annual Scientific Symposium sponsored by the Wilmot Cancer Institute on Nov. 13.
11/14/2014 | 0 comments
UR Pathology Professor David G. Hicks, M.D., a national leader in using molecular technology to diagnose breast cancer, helped to design a new tool to assist other U.S. pathologists in how to personalize treatment for patients with invasive disease.
7/31/2014 | 0 comments
The National Cancer Institute awarded more than $2 million to a team at the Wilmot Cancer Institute to continue their study of a gene network that controls cancer progression, with a focus on pancreatic cancer.
6/25/2014 | 0 comments
One of the big topics in cancer research is immunotherapy and the need for a new generation of drugs that spur the immune system to fight tumors. John Frelinger’s lab was featured in a news article in the journal Nature, for its work on refining interleukin-2.
6/4/2014 | 0 comments